labetalol has been researched along with urapidil in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (40.00) | 18.7374 |
| 1990's | 2 (13.33) | 18.2507 |
| 2000's | 4 (26.67) | 29.6817 |
| 2010's | 3 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Johans, C; Kinnunen, PK; Söderlund, T; Suomalainen, P | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| van Zwieten, PA | 2 |
| Prichard, BN; Van Zwieten, PA | 1 |
| Dollery, CT; Warren, JB | 1 |
| Doyle, AE | 1 |
| Holzmann, A; Loupal, G; Stackl, W | 1 |
| Bacher, S; Beck, A; Kraupp, O; Raberger, G; Skoda, H | 1 |
| Heintz, B; Kirsten, D; Kirsten, R; Nelson, K | 1 |
| Arcega, JM; Bernardo, M; Blanch, J; Faulí, A; Gomar, C; Imaz, ML; Martínez-Pallí, G; Navinés, R; Santos, P | 1 |
4 review(s) available for labetalol and urapidil
| Article | Year |
|---|---|
Basic pharmacology of alpha-adrenoceptor antagonists and hybrid drugs.
Topics: Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Chemical Phenomena; Chemistry; Humans; Ketanserin; Labetalol; Piperazines | 1988 |
The usefulness of alpha-adrenoceptor blockade in the treatment of hypertension.
Topics: Adrenergic alpha-Antagonists; Antihypertensive Agents; Humans; Hypertension; Indoramin; Labetalol; Piperazines; Prazosin | 1988 |
Do hybrid drugs offer an additional benefit over pure alpha 1-blockade for hypertensive patients?
Topics: Adrenergic alpha-Antagonists; Antihypertensive Agents; Humans; Hypertension; Ketanserin; Labetalol; Piperazines | 1988 |
Clinical pharmacokinetics of vasodilators. Part II.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Alprostadil; Amrinone; Carbazoles; Carvedilol; Enoximone; Female; Humans; Iloprost; Imidazoles; Indoramin; Isosorbide Dinitrate; Labetalol; Milrinone; Molsidomine; Nitroglycerin; Nitroprusside; Oxyfedrine; Pentaerythritol Tetranitrate; Phosphodiesterase Inhibitors; Piperazines; Prazosin; Pregnancy; Propanolamines; Pyridones; Theophylline; Trapidil; Vasodilator Agents | 1998 |
1 trial(s) available for labetalol and urapidil
| Article | Year |
|---|---|
Comparative hemodynamic effects of urapidil and labetalol after electroconvulsive therapy.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Dose-Response Relationship, Drug; Electroconvulsive Therapy; Electroencephalography; Female; Heart Rate; Humans; Hypertension; Labetalol; Male; Middle Aged; Piperazines | 2001 |
10 other study(ies) available for labetalol and urapidil
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Surface activity profiling of drugs applied to the prediction of blood-brain barrier permeability.
Topics: Blood-Brain Barrier; Lipid Bilayers; Micelles; Permeability; Pharmaceutical Preparations; Structure-Activity Relationship; Surface Properties | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Hybrid or multifactorial drugs in antihypertensive treatment.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Antihypertensive Agents; Drug Combinations; Humans; Hypertension; Labetalol; Piperazines; Serotonin Antagonists; Vasodilator Agents | 1990 |
An antihypertensive drug with polyfactor mechanism of action: urapidil.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Brain Chemistry; Cats; Humans; Ketanserin; Labetalol; Piperazines; Rats; Receptors, Adrenergic; Receptors, Serotonin | 1989 |
Intracavernous injection of vasoactive drugs in the rabbit.
Topics: Animals; Cavernous Sinus; Injections; Labetalol; Male; Papaverine; Penile Erection; Phenoxybenzamine; Phentolamine; Piperazines; Prostaglandins E; Rabbits; Vasoconstrictor Agents; Vasodilator Agents | 1988 |
Characterization of vasodilators by comparison of their effects on blood pressure, counterregulation and myocardial oxygen demand in conscious normotensive dogs.
Topics: Animals; Blood Pressure; Dihydralazine; Dogs; Female; Heart Rate; Isosorbide Dinitrate; Labetalol; Male; Molsidomine; Myocardium; Oxygen Consumption; Piperazines; Prazosin; Pyridazines; Renin; Sydnones; Vasodilator Agents | 1985 |